Professional Seasonal Analysis for Trading

Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

Seasonality Analysis

Stocks 5 Years Analyzed

Anebulo Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

-24.12%
Avg Annual Return
46.7%
Avg Monthly Win Rate
4/12
Positive Months
5
Years Analyzed

Anebulo Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 1.83%
60%
Moderate
February -15.34%
40%
Weak
March BEST 28.98%
80%
Very Strong
April WORST -17.21%
60%
Weak
May -13.15%
20%
Very Weak
June 24.88%
60%
Moderate
July -0.63%
40%
Weak
August -3.71%
40%
Weak
September 0.89%
60%
Moderate
October -9.78%
20%
Very Weak
November -13.09%
20%
Very Weak
December -7.79%
60%
Weak

Anebulo Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
18.95
Historical Avg Position
48.59
Deviation
-29.64
Performance
Significantly Below Average

Anebulo Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ANEB with overlay patterns, custom date ranges, and more.

Create Free Account

Anebulo Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Anebulo Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for ANEB across multiple timeframes.

Create Free Account

About Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) Seasonality

Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, Anebulo Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Anebulo Pharmaceuticals, Inc. - Common Stock is historically March, with an average return of 28.98% and a win rate of 80%. Conversely, April tends to be the weakest month, averaging -17.21% return.

Looking at the full calendar year, Anebulo Pharmaceuticals, Inc. - Common Stock has an average annual return of -24.12% with an overall monthly win rate of 46.7%. Out of 12 months, 4 typically show positive average returns.

The seasonal pattern for Anebulo Pharmaceuticals, Inc. - Common Stock has a consistency score of 57.7 (Fair), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Anebulo Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)?

Historically, March has been the best month for Anebulo Pharmaceuticals, Inc. - Common Stock, with an average return of 28.98% and a win rate of 80%. However, past performance does not guarantee future results.

What is the worst month for Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)?

Based on historical data, April has been the weakest month for Anebulo Pharmaceuticals, Inc. - Common Stock, with an average return of -17.21%. This is a historical observation and does not guarantee future results.

How reliable is ANEB seasonality data?

The seasonality analysis for Anebulo Pharmaceuticals, Inc. - Common Stock is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Anebulo Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.